Building A Sustainable Market: New Medicines For Europe President Sets Out Priorities

Stada’s Stephan Eder Discusses Association’s Key Objectives

Recently-appointed president of Medicines for Europe Stephan Eder speaks to Generics Bulletin about the off-patent association’s priorities to secure a sustainable operating environment for the generics, biosimilars and value-added medicines sector in Europe.

Stephan Eder recently became Medicines for Europe’s new president (Medicines for Europe)

More from Interviews

More from Value Added Medicines